Walid Al Zarooni, W Capital CEO DUBAI / GULF TIME W Capital, a Dubai-based real ...
Read More »AstraZeneca to pay Daiichi $6bn for new cancer drug
Bloomberg AstraZeneca Plc agreed to pay as much as $6 billion to buy into a promising medicine for lung and breast cancer in the second potential blockbuster oncology deal in two years with Japan’s Daiichi Sankyo Co. The UK drugmaker will pay Daiichi $1 billion upfront to jointly develop and bring to market a cancer therapy in early clinical tests ...
Read More »